Abstract
Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have